glp-1 weight loss marketing Prescription by Algorithm: The Ethical and Legal Questions Behind Advertising Is GLP-1 Marketing Attacking Our

When used for overweight or obesity, the drugs are typically prescribed in higher doses than when prescribed for diabetes

Not achieving miracle results or plateauing weight loss could lead to discontinuation of GLP-1s for some patients

Transitioning from other compounds Researchers switching from tirzepatide to retatrutide should be aware that they may experience a noticeable increase in heart rate effects due to the addition of glucagon receptor activation

Weight loss, not diabetes, is driving GLP-1 use

102 The latter, glucagon, is a basic glucose-regulating hormone with catabolic and thermogenic actions, but it also increases glucose levels and the risk of gluconeogenesis